Fierce Biotech July 21, 2022
Sponsored by PathAI

Mike Montalto, Chief Scientific Officer at PathAI , sat down with Joseph Szustakowski, VP of Translational Bioinformatics at Bristol Myers Squibb [BMS], to discuss AI-powered digital pathology. Learn how BMS is unlocking new insights in translational research and development by injecting innovative computational AI-based approaches into the traditional field of pathology.

MM: Hi Joe, thanks for taking the time today to discuss recent innovation and approaches in AI-powered digital pathology, especially in the context of your experience at Bristol Myers Squibb. To start, can you talk about your role at BMS, the role of your organization, and how digital pathology fits into that organization?

JS: Sure, I lead a computational research organization that’s called Translational Bioinformatics. We are a team with diverse...

Today's Sponsors

Amwell
Oliver Wyman
Upfront Healthcare

Today's Sponsors

Qure4u
H1

Today's Sponsor

HealthITq

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
Q&A - The Growing Importance of Pharma Services with Colin Aldridge, Director at TripleTree
Consolidation Forces Pharma to Rethink Commercial Strategies: Q&A with Beghou Consulting’s Rohit Gupta
'The Top Line' podcast: The brouhaha over the landmark drug pricing bill, what's behind Pfizer's $5.4B Global Blood Therapeutics buyout deal, plus more
Why diverse clinical trials matter: the pharmaphorum podcast
Podcast: High Drug Prices and PBM (6/10/22)